Drug Profile
Recanaclotide - Ironwood Pharmaceuticals
Alternative Names: IW-9179Latest Information Update: 18 Sep 2019
Price :
$50
*
At a glance
- Originator Ironwood Pharmaceuticals
- Class Antiulcers; Gastrokinetics; Peptides
- Mechanism of Action Enterotoxin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic gastroparesis; Dyspepsia